Headache as Adverse Effect of Hormonal contraception

Key points
- Almost 18% of the women suffering from migraine headaches and, the last Classification of Headache Disorders of the International Headache Society clearly identifies an "exogenous hormone-induced headache" that could be triggered by intake of combined oral contraceptives(COCs).
- It is known that headache can be related to estrogen exposure,during pill intake and after hormone withdrawal an the pill free interval(1,2).
- Migraine in the pill-free interval of combined oral contraceptives is reported by many women.
- Therefore, continuous regimen- HCs (hormonal contraceptives) may represent a convenient strategy as preventive therapy reducing the frequency, duration and intensity of attacks (4).
Almost 18% of the women suffering from migraine headaches and, the last Classification of Headache Disorders of the International Headache Society clearly identifies an "exogenous hormone-induced headache" that could be triggered by intake of combined oral contraceptives(COCs).
It is known that headache can be related to estrogen exposure,during pill intake and after hormone withdrawal an the pill free interval(1,2).
Migraine in the pill-free interval of combined oral contraceptives is reported by many women. A pilot study suggest that the use of 50 μg estrogen patch during the pill-free interval may reduce the frequency and severity of migraine at that time (3).
Therefore, continuous regimen- HCs (hormonal contraceptives) may represent a convenient strategy as preventive therapy reducing the frequency, duration and intensity of attacks (4).
The newest formulations influence the headache course to a lesser extent than previous hormonal contraceptives; although, migraine and pill intake are associated both, with an increased risk of ischaemic stroke.
Whatever, migraine per se is not a contraindication for COCs use (5). Anyway, it is very important to remember that patients suffering from migraine with aura, generally show a greater thrombotic risk than women with migraine without aura.
{embed="ref/stat-menu-obgyn2"}
Other risk factors as patient's age, tobacco use, hypertension, hyperlipidaemia, obesity and diabetes must be carefully considered, when prescribing COCs in migraine patients. A thorough laboratory control of the genetics of prothrombotic factors and coagulative parameters should precede any decision of COCs prescription in migraine patients.
Migraine has been considered to be benign,not life-threatening illness. In spite of this, several studies suggested it as a rare risk factor for ischaemic stroke. Six cases of migrainous stroke fully meeting the diagnostic criteria of the International Headache Society (HIS) were reported and all patients had migraine with aura (6).
This association is still conflicting and seems to be restricted to particular subgroups as the women under 45 years of age, with migraine with aura, who smoke and use hormonal contraceptives.
Furthermore, epidemiological studies disclosed the risk of stroke is raised in women who has been suffering from migraine in their younger time (7).
A large cross-sectional population-based study carried out in 46,506 women using hormonal contraceptives showed a significant dose relationship between headache and estrogen; while, no significant association between headache and COCs containing only progestagen was found (1).
----
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Women's Health →
GuideColorectal cancer risk of Hormonal Contraception
The association between oral contraceptive use and colorectal cancer have yielded conflicting results. The analysis from a multicenter case-control study, conducted in 6 Italian regions in 1992-96 with data from a…
8 June 2010
GuideCervical cancer risk of Hormonal Contraception
In some studies HCs have been associated with an increased risk of cervical abnormalities and cervical cancer, but there might be alternative explanations for these epidemiological associations: HC users can start…
8 June 2010
GuideEndometrial cancer risk of Hormonal Contraception
Combination oral contraceptive use was associated with a decreased risk in endometrial carcinoma, which decrease with duration of use (RR=0.28 at 5 years of use); however, the estimated protective effect was reduced and…
8 June 2010




